The future of REACH in toxicology lies in the continued development and acceptance of non-animal testing methods and the integration of big data and artificial intelligence in risk assessment processes. The ongoing collaboration between regulatory bodies, industry, and scientific communities will be crucial in advancing these technologies and methodologies to enhance the efficiency and effectiveness of chemical safety assessments under REACH.
